-+ 0.00%
-+ 0.00%
-+ 0.00%

PALVELLA THERAPEUTICS APPOINTS ACCOMPLISHED RARE DISEASE BIOTECH EXECUTIVE AND COMMERCIAL LEADER MATT PAULS, J.D., M.B.A., TO BOARD OF DIRECTORS

Reuters·06/30/2026 11:30:01

Please log in to view news